AT&T's chief data officer shares how rearchitecting around small language models and multi-agent stacks cut AI costs by 90% at 8 billion tokens a day.
Arcus Biosciences, Inc. , a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for patients with cancer and inflammatory and ...
Archrock, Inc. (NYSE: AROC) ("Archrock" or the "Company") today reported results for the fourth quarter and full year 2025. Fourth Quarter and Full Year 2025 ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する